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Abstract Expansion of the vasa vasorum network has
been observed in a variety of systemic and pulmonary
vascular diseases. We recently reported that a marked
expansion of the vasa vasorum network occurs in the
pulmonary artery adventitia of chronically hypoxic calves.
Since hypoxia has been shown to stimulate ATP release
from both vascular resident as well as circulatory blood
cells, these studies were undertaken to determine if extra-
cellular ATP exerts angiogenic effects on isolated vasa
vasorum endothelial cells (VVEC) and/or if it augments the
effects of other angiogenic factors (VEGF and basic FGF)
known to be present in the hypoxic microenvironment. We
found that extracellular ATP dramatically increases DNA
synthesis, migration, and rearrangement into tube-like
networks on Matrigel in VVEC, but not in pulmonary
artery (MPAEC) or aortic (AOEC) endothelial cells
obtained from the same animals. Extracellular ATP
potentiated the effects of both VEGF and bFGF to stimu-
late DNA synthesis in VVEC but not in MPAEC and
AOEC. Analysis of purine and pyrimidine nucleotides
revealed that ATP, ADP and MeSADP were the most
potent in stimulating mitogenic responses in VVEC, indi-
cating the involvement of the family of P2Y1-like
purinergic receptors. Using pharmacological inhibitors,
Western blot analysis, and Phosphatidylinositol-3 kinase
(PI3K) in vitro kinase assays, we found that PI3K/Akt/
mTOR and ERK1/2 play a critical role in mediating the
extracellular ATP-induced mitogenic and migratory
responses in VVEC. However, PI3K/Akt and mTOR/
p70S6K do not signiﬁcantly contribute to extracellular
ATP-induced tube formation on Matrigel. Our studies
indicate that VVEC, isolated from the sites of active
angiogenesis, exhibit distinct functional responses to ATP,
compared to endothelial cells derived from large pulmon-
ary or systemic vessels. Collectively, our data support the
idea that extracellular ATP participates in the expansion of
the vasa vasorum that can be observed in hypoxic
conditions.
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Introduction
Angiogenesis, the formation of new capillaries from pre-
existing blood vessels, occurs during normal embryonic
development and in various pathological conditions where
hypoxia, ischemia, or inﬂammation are prominent features
[1, 2]. In a neonatal model of hypoxic pulmonary hyper-
tension, we have demonstrated that adventitial thickening
and expansion of the vasa vasorum network, are especially
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eling process [3, 4]. In the pulmonary arteries, the vasa
vasorum is the microcirculatory network of the bronchial
(systemic) circulation and, similar to its role in systemic
vessels, is thought to contribute to vascular integrity
through supply of oxygen and nutrients to the outer part of
the vessel wall. However, an increasing body of experi-
mental data has demonstrated that the expansion of the
vasa vasorum might also contribute to the progression of
certain vascular diseases in systemic circulation including
atherosclerosis, restenosis, and vasculitis, suggesting that
neovascularization of the vasa vasorum might be an
important common feature of speciﬁc pulmonary and
systemic vascular diseases [5–7]. At present, the precise
cellular mechanisms and endogenous molecular factors
contributing to this process of neovascularization in the
vessel wall are not completely understood.
Endogenous soluble autocrine and paracrine factors
released under hypoxic conditions from cells of the vas-
cular wall and circulating blood cells are important
contributors to angiogenesis [8–12]. Extracellular purine
and pyrimidine nucleotides ATP, ADP, AMP, UTP, UDP
act as ligands for P2Y (metabotropic) and P2X (ionotropic)
purinergic receptors and are increasingly recognized as
important regulators of a variety vascular functions,
including vascular tone, permeability, inﬂammation, and
thrombosis [13–16]. Elevated concentrations of extracel-
lular ATP are thought to be present in the local
microenvironment in various physiological and pathologi-
cal conditions including hypoxia, thrombosis, sympathetic
stimulation (when ATP is co-released with noradrenalin),
and tissue damage, suggesting that different types of stress
conditions could contribute to elevated extracellular ATP
levels in the vascular wall. A number of studies support the
idea that extracellular nucleotides could contribute to the
development of vascular disease. Extracellular ATP has
been implicated in the hyperplasia and hypertrophy of
arterial walls in spontaneously hypertensive rats [17], in the
regulation of vascular permeability [18, 19], and in the
control of proliferation and migration of vascular smooth
muscle cells and hematopoietic stem cells [20–23]. For
example, purinergic antithrombotic drugs reduce the risk of
recurrent strokes and heart attacks [24]. Further, in endo-
thelial cells, ATP- and UTP-induced stimulation of P2Y2
receptors is associated with the co-activation of VEGF
receptor-2, expression of Vascular Cell Adhesion Mole-
cule-1 (VCAM-1), and monocyte recruitment, implying a
link between purinergic signaling, angiogenesis, and
inﬂammatory responses [25, 26]. A product of extracellular
ATP hydrolysis, adenosine, has been shown to be angio-
genic for both microvascular and macrovascular
endothelial cells [27–29]. Importantly, ATP has been
reported to act synergistically with cytokines (e.g., platelet-
derived growth factor, epidermal growth factor, and insu-
lin-like growth factor) and integrins to stimulate vascular
cell proliferation and migration, thereby increasing the
potential importance of extracellular ATP under various
pathologic conditions [20, 30–32]. However, a role for
extracellular ATP in the angiogenic process has not been
established.
Since chronic hypoxic exposure stimulates angiogenesis
of the pulmonary artery vasa vasorum in neonatal calves
but not, to our knowledge, of other vascular beds in the
same animals, and because hypoxia has been shown to
stimulate release of ATP from bovine neonatal endothelial
cells, the purpose of this study was to determine whether
extracellular ATP exerts angiogenic effects on vasa vaso-
rum endothelial cells that were distinct from pulmonary
artery or aortic endothelial cells, and to determine the
signaling pathways utilized in these responses. Using
established cultures of vasa vasorum endothelial cells
(VVEC) isolated from PA adventitia of chronically hyp-
oxic animals as well as pulmonary artery and aortic
endothelial cells derived from the same animals, we com-
pared the effects of ATP and other purine and pyrimidine
nucleotides on various parameters associated with angio-
genesis such as proliferation, migration, and tube formation
on Matrigel. We also assessed the effects of known
angiogenic factors with and without extracellular ATP on
mitogenesis in these cell types. We also sought to deﬁne
the signaling pathways through which these effects were
mediated. Based on preliminary data and ﬁndings in other
cell types, emphasis was placed on the PI3K/Akt, mTOR/
p70S6K and ERK1/2 pathways.
Materials and methods
Cultures of vasa vasorum endothelial cell
from pulmonary artery adventitia
Pulmonary artery adventitia was dissected from the media,
extensively washed from blood in phosphate-buffered sal-
ine solution (PBS), and enzymatically digested for 1.5–2 h
at 37C in a mixture containing collagenase type 2
(0.5 mg/ml), elastase (0.5 mg/ml), bovine albumin (2 mg/
ml), and soybean trypsin inhibitor (0.02 mg/ml). Dispersed
cell mixtures were ﬁltered through a 100 lM nylon cell
strainer (BD Biosciences, San Diego, CA), plated on 6-well
plates and grown in DMEM media supplemented with 10%
fetal bovine serum (FBS) and Endothelial Growth Sup-
plement (Upstate Biotechnology, Charlottesville, VA).
VVEC were puriﬁed from the co-cultures with adventitial
ﬁbroblasts using cloning rings and trypsinization tech-
niques. Isolated VVEC have been shown to express
endothelial markers, including vWF, eNOS, and PECAM-1;
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incorporate acetylated low-density lipoproteins labeled
with 1,10-dioctadecyl-3,3,30,30-tetramethylindo-carbocya-
nine perchlorate (DiI-Ac-LDL) [33, 34].
DNA synthesis
DNA synthesis was determined by [methyl-
3H] thymidine
incorporation previously performed by Gerasimovskaya
et al. [31]. Cells were plated in 24-well plates at a density
of 12,000 cells per well in DMEM, supplemented with
10% FBS. On the next day cells were rinsed with phos-
phate-buffered saline (PBS), and incubated in DMEM
without serum for 72 h. Cells were stimulated with extra-
cellular ATP (10
-9–10
-3 M), VEGF (10 ng/ml), basic
FGF (bFGF, 10 ng/ml), ATP and VEGF, or ATP and bFGF
as indicated in the ﬁgure legends. In the experiments
designed to evaluate a role of PI3K, mTOR, and ERK1/2
pathways, cells were pre incubated with or without
LY294002 (20 lM, 60 min), wortmannin (100 nM 2–6 h),
rapamycin (10 nM, 60 min), or U0126 (10 lM, 60 min)
(Cell Signaling, Danvers, MA) and then stimulated with
ATP (100 lM) in the presence of 0.125 lCi of [methyl-
3H]
thymidine (NEN Life Science Products, Boston, MA), for
24 h. To stop the incubation, VVEC were washed twice
with 1 ml of PBS, incubated with 0.5 ml of 0.2 M per-
chloric acid for 3 min, washed with PBS, and lysed in
0.3 ml of 1% SDS containing 0.1 M NaOH. Thereafter
samples were harvested, mixed with liquid scintillation
cocktail (Ecoscint H, National Diagnostics, Atlanta, GA),
and incorporated [methyl-
3H] thymidine was counted
(cpm/min) in a scintillation b-counter (Beckman LS 6500).
Migration assay
Growth-arrested cells (VVEC, AOEC, or MPAEC,
100,000 cells/well) were plated in 200 ll of serum-free
DMEM in permeable cell culture inserts (polycarbonate
membrane, 8.0 lM pore size, Falcon
TM) precoated with
0.1% gelatin (Sigma, St. Louis, MO). ATP (100 lM) was
added in the lower chamber containing 800 ll of serum-
free DMEM. In some of the experiments, the effect of ATP
on endothelial cell migration was determined in the media,
supplemented with 2% fetal bovine serum. To evaluate the
contribution of PI3K, mTOR, and ERK1/2 pathways to
VVEC migration, cells in transwells were pre incubated
with LY294002 (20 lM), wortmannin (100 nM), rapamy-
cin (10 nM), or U0126 (10 lM) for 60 min. After 24 h
incubation, cells remaining on the upper surface of the
ﬁlter were wiped off, and migrated cells were ﬁxed with
methanol for 15 min and stained with 0.2% crystal violet in
2% (v/v) ethanol for a minimum of 15 min. Cell migrated
through ﬁlter were photographed under 409 magniﬁcation
of a phase contrast microscope in six random ﬁelds.
In vitro Matrigel assay
The Matrigel in vitro tube-formation assay was performed
using Growth Factor-Reduced (GFR) Basement Membrane
Matrix (BD Bioscience, Bedford, MA). Matrigel (300 ll/
well) was polymerized in 24-well plates for 60 min at
37C. Growth-arrested VVEC (125,000 cells/well) were
plated on top of Matrigel either with or without inhibitors
of PI3K, mTOR, or ERK1/2. After 60 min incubation, ATP
(100 lM) was added to the half of the wells. When AOEC
and MPAEC were tested, both cell types were plated at the
density 200,000 cells/well in 24-well plates and incubated
either with or without ATP (100 lM). Tube formation was
visualized after 8–10 h of incubation with a 940 objective
with a phase contrast microscope (Nikon) equipped with
digital camera. For each experimental condition, three
images were captured. Tube length and area of cell
aggregates were quantiﬁed using AxioVision (Zeiss). Both
parameters were measured using the length tool. Data are
presented in pixels.
In vitro PI3K activity assay
Endothelial cells were cultured to 80% conﬂuence in
100 mm
2 dishes, growth-arrested in DMEM without serum
for 72 h and then stimulated with ATP (100 lM) or FBS
(10%) for 30 min. After stimulation, cells were washed two
times with ice-cold PBS, containing 0.2 mM activated
orthovanadate, and incubated in 750 ll of lysis buffer,
containing 137 mM NaCl, 20 mM Tris-HCl, pH 7.5,
1 mM MgCl2, 1 mM CaCl2, 10% glycerol, 1% Nonidet P-
40, 1 mM sodium orthovanadate, 1 mM PMSF, and com-
plete protease inhibitor cocktail (Calbiochem, La Jolla,
CA) and incubated for 20 min at +4C. Cell lysates were
transferred to 1.5 ml tubes and centrifuged at 10,000g for
10 min to sediment-insoluble material. Supernatants were
normalized for protein content (Bio-Rad protein assay kit)
and PI3K was immunoprecipitated using the Catch and
Release
TM immunoprecipitation system (Upstate Biotech-
nology). The phosphorylation reaction (ﬁnal volume 80 ll)
was started by addition of 10 ll of mixture, containing
15 lCi [c-
32P] ATP (10 mM, 3,000 Ci/mmol) and 0.88 ll
of 10 mM ATP to 50 ll of eluate containing PI3K. The
samples were incubated for 15 min at 37C, and the
reaction was stopped by the addition of 20 ll of 6N HCl.
Radiolabeled lipids were extracted with 160 ll of chloro-
form-methanol mixture (1:1, vol:vol.). The organic phase
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4C, and lipids were separated on oxalate-coated silicon
TLC plates (Silica Gel 60, Sigma) by chromatography in a
CH3: MeOH:H2O:NH4OH (60:40:11.3:2 by vol.) solvent
system in parallel with a non-radioactive standard.
Cell extracts and Western blot analysis
VVEC were cultured to near conﬂuence and serum -starved
in DMEM for 48–72 h. For the experiments with PI3K,
mTOR and ERK1/2 inhibitors cells were pre incubated
with LY294002, wortmannin, rapamycin, or U0126, as
described in the ﬁgure legends. Cells were stimulated with
ATP (100 lM) in serum-free media for variable periods of
time. After stimulation, VVEC were washed twice with
ice-cold PBS and lysed with Tris-HCl buffer (40 mM
pH 7.5, 4C), containing 0.1% Triton X-100, 0.25 M
sucrose, 3 mM EGTA, 3 mM EDTA, 50 lM b-mercapto-
ethanol, 1 mM PMSF and complete protease inhibitor
cocktail (Calbiochem). Cell lysates were centrifuged at
7,500g for 10 min at +4C, and supernatant fractions were
collected and stored at -80C. Equivalent amounts of total
cell protein (20–40 lg) were subjected to 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Proteins were transferred to PVDF membranes and
probed with rabbit polyclonal antibodies against phospho-
ERK1/2 (Tyr202/Thr204), phospho-p70S6K (Thr421/Ser424),
phospho-Akt (Ser473), phospho-mTOR (Ser2448), fol-
lowing conditions recommended by the manufacturer (Cell
Signaling Technology). After washing with TBS-Tween
buffer, membranes were incubated with donkey anti-rabbit
peroxidase-conjugated IgG 1:20,000 dilution, (Amersham
Bioscienses, Piscataway, NJ), for 1 h at room temperature.
Immunoreactive bands were detected by ECL kit
(Renaissance, NEN Life Science Product) followed by
exposure to Hyperﬁlm. In all experiments, equivalent
sample loading and transfer was veriﬁed by staining PVDF
membrane with Ponseau or probing with antibodies against
non-phosphorylated form of indicated proteins or b-actin.
Statistical analysis
Data are expressed as mean ± standard error (SE); n
equals the number of replicates in one experiment or a
number of observations in independent experiments. To
evaluate signiﬁcance of the obtained data, Student–New-
man-Keuls or Bonferroni tests followed by one-way
ANOVA were performed using GraphPad Prism 3.0
(GraphPad Software). A value of P\0.05 was considered
statistically signiﬁcant.
Results
Extracellular ATP stimulates DNA synthesis in VVEC,
but not in AOEC or MPAEC
Several lines of evidence have demonstrated that in
response to hypoxia, endothelial cells of both pulmonary
and systemic vessels release ATP into the extracellular
space [13, 17, 34, 35]. The effects of the released extra-
cellular ATP on endothelial function have not been fully
elucidated. Speciﬁcally, whether extracellular ATP is
directly involved in endothelial angiogenesis remains
unexplored. To address this question, we examined the
effect of extracellular ATP on DNA synthesis in VVEC
as well as main pulmonary artery (MPAEC) and aortic
endothelial cells (AOEC) isolated from the same animals.
Extracellular ATP at concentrations of 10
-6–10
-3 M
robustly (5–12 fold) increased DNA synthesis in quiescent
VVEC (Fig. 1a). The mitogenic effect of extracellular
ATP far exceeded those observed in AOEC and MPAEC,
where DNA synthesis was only minimally affected
(Fig. 1b, c).
Extracellular ATP is rapidly hydrolyzed by endothelial
ecto-nucleotidases/NTPDases to ADP, AMP, and adeno-
sine. Since ATP hydrolysis products might be expected to
contribute to an increase in DNA synthesis, we examined
the effects of various adenine nucleotides, their non-hy-
drolyzable synthetic analogs, and UTP and UDP on DNA
synthesis in VVEC, MPAEC, and AOEC. As shown in
Table 1, ATP, ADP, and MeSADP signiﬁcantly increased
[methyl-
3H] thymidine incorporation in VVEC more than
5-fold. AMP, Ado, ADPbS, ATPcS, MeSATP, and
bcMeATP also had signiﬁcant effects on [methyl-
3H]
thymidine incorporation with variable potency (2–5 fold).
abMe-ATP, BZ-ATP, and Ap4A were not effective. Sur-
prisingly, no signiﬁcant changes in DNA synthesis were
observed in response to pyrimidine nucleotides (UTP and
UDP). The efﬁcacy of extracellular nucleotides in
increasing DNA synthesis suggests that the P2Y1 family of
G protein-coupled purinergic receptors (P2Y1, P2Y11,
P2Y12, P2Y13) is likely involved in mediating the effect of
extracellular adenine nucleotides in VVEC. As shown in
Table 1, UTP, UDP, adenosine, and all tested nucleotide
analogs did not have a signiﬁcant effect on DNA synthesis
in AOEC and MPAEC. Thus, VVEC isolated from the sites
of active neovascularization exhibit a distinct proliferative
phenotype to extracellular adenine nucleotides, particu-
larly, ATP and ADP.
Many growth factors and cytokines known to be
involved in angiogenic process including VEGF and
bFGF are increased by hypoxia and are present in the
hypoxic pulmonary artery microenvironment [33].
Therefore, we next evaluated the effect of VEGF and
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ATP, in these cell types of interest. We found that in
VVEC, VEGF induced about 2.4-fold increase in DNA
synthesis (Fig. 2). In these cells, the response to VEGF
was potentiated by simultaneous stimulation with extra-
cellular ATP. In AOEC and MPAEC, VEGF induced
increases in DNA synthesis by 1.24- and 2.42-fold,
respectively, but in contrast to VVEC, co-stimulation with
extracellular ATP resulted in only modest potentiation of
DNA synthesis (Fig. 2). bFGF induced 5-fold increase in
DNA synthesis in VVEC, and in 1.6- and 1.9-fold
increases in AOEC and MPAEC, respectively. The
responses to bFGF were signiﬁcantly potentiated by
extracellular ATP in VVEC, but not in AOEC and
MPAEC. Together, these data demonstrated differential
endothelial proliferative responses to stimulation with
VFGF and bFGF. Further extracellular ATP potentiates
growth factor-mediated responses in a cell type-speciﬁc
manner. The responses to ATP in combination with
growth factors are predetermined by the ability of the
endothelial cell to proliferate in response to ATP.
Extracellular ATP induces migration of VVEC
but not AOEC and MPAEC
Endothelial cell migration is an important step in the
angiogenesis process. Therefore, to further characterize
angiogenic responses to extracellular ATP, we examined
the effect of ATP on migration of VVEC, AOEC, and
MPAEC. Our preliminary observations demonstrated a
high migratory capability of VVEC in response to 0.1–10%
fetal bovine serum (FBS). Therefore, elimination of FBS
from the media was necessary to assess the direct effect of
extracellular ATP on endothelial migration. As shown in
Fig. 3, extracellular ATP (100 lM) stimulated VVEC
migration up to 8-fold. The observed response was com-
parable in magnitude to the response elicited by 2% FBS
(Fig. 3a, b). Stimulation of VVEC with ATP (100 lM) and
2% FBS had an additive effect on cell migration. However,
at a concentration of 5% or higher, FBS completely
masked the effect of extracellular ATP (not shown). No
migratory responses to ATP were observed in AOEC and
MPAEC under the same experimental conditions where
Fig. 1 Extracellular ATP stimulates DNA synthesis in VVEC, but
not in AOEC or MPAEC. Growth-arrested (72 h, serum-free DMEM)
vasa vasorum endothelial cells (VVEC, Panel a), aorta endothelial
cells (AOEC, Panel b), and main pulmonary artery endothelial cells
(MPA, Panel c), were stimulated with extracellular ATP from 10
-9 to
10
-3 M in the presence of 0.125 lCi [
3H]-thymidine for 24 h.
Incorporated radioactivity was determined in total cell lysates as
described in MATERIALS AND METHODS. The results are
expressed as means ± SE; *P\0.05 vs. nonstimulated control
(n = 3). Please note the different scale of Y-axis on Panels a–c.
Data illustrate one representative experiment for each cell type.
Similar results have been obtained from three to six independent
experiments conducted on distinct cell populations
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(Fig. 3c).
Extracellular ATP induces VVEC but not AOEC
and MPAEC rearrangements into tube-like networks
on Matrigel
In addition to proliferation and migration, interaction of
endothelial cells with extracellular matrix is integral to the
angiogenic process. Using an in vitro Matrigel assay, we
explored the possibility that incubation of endothelial cells
from different sources with ATP would stimulate cell
rearrangements into tube-like networks. Plating of quies-
cent VVEC on growth factor-reduced (GFR) Matrigel in a
serum-free media resulted in a pattern of aligned and
aggregated cell structures, though no distinguishable net-
work formation was observed within 18 h of plating
(Fig. 4a, -ATP). In the presence of extracellular ATP
(100 lM, 6 h), VVEC assembled in a pattern of tube-like
structures (Fig. 4a, +ATP). Calculated areas of total
and average tube length increased more than 3-fold in
ATP-stimulated cells (Fig. 4b, d). No signiﬁcant changes
were observed in the total and average diameter of the
endothelial cell aggregates (Fig. 4c, e) suggesting a pre-
dominant effect of extracellular ATP on cell mobility
rather than stabilization of cell-cell and/or cell-matrix
interaction. The tube-like structures were stable for 6 and
10 h followed by the regression between 10 and 18 h.
We found that AOEC and MPAEC rearranged into
pattern of tube-like networks within 6 h of plating on GFR
Matrigel (Fig. 4a). In AOEC, extracellular ATP (100 lM)
induced an approximately two-fold increase in total tube
length, but total cell aggregate diameter, average tube
length, and average cell aggregate diameter remained
unchanged. In MPAEC, extracellular ATP (100 lM) had
only a negligible effect on network formation (Fig. 4b–e).
Extracellular ATP robustly activates ERK1/2, PI3K,
and mTOR signaling pathways in VVEC but only
modestly in AOEC and MPAEC
Studies in vivo and in vitro have shown the importance of
ERK1/2 and PI3K/mTOR pathways in controlling angio-
genesis-related events and metastatic tumor growth [36–
40]. Because of the differences in ATP-induced prolifera-
tive and migratory responses in VVEC, AOEC, and
MPAEC, we examined the effects of ATP on activation of
ERK1/2 (as measured by Thr202/Tyr204 phosphorylation),
Akt (as measured by Ser473 phosphorylation), mTOR (as
measured by Ser2448 phosphorylation), and p70S6K (as
measured by Thr421/Ser424 phosphorylation) in the
Table 1 The effects of purine and pyrimidine nucleotides and non-
hydrolyzable nucleotide analogs on DNA synthesis in VVEC, AOEC,
and MPAEC
Agonist (100 lM) VVEC AOEC MPAEC
Basal 100 100 100
ATP 560 ± 112** 112 ± 1 116 ± 10
ADP 605 ± 74** 143 ± 7 118 ± 8
AMP 488 ± 72* 141 ± 8 112 ± 16
Ado 249 ± 45* 100 ± 89 6 ± 44
ATPcS 335 ± 72* 140 ± 10 122 ± 8
ADPbS 308 ± 117* 141 ± 11 114 ± 12
UTP 150 ± 27 109 ± 15 80 ± 14
UDP 97 ± 4 100 ± 27 9 ± 11
MeSATP 290 ± 44* 132 ± 8 111 ± 12
MeSADP 564 ± 257** ND 102 ± 10
abMeATP 141 ± 36 129 ± 10 114 ± 9
bcMeATP 253 ± 121 126 ± 8 105 ± 6
BzATP 200 ± 85 126 ± 18 91 ± 14
Ap4A 198 ± 58 112 ± 3 111 ± 7
The effect of various nucleotides and nucleotide analogs was evalu-
ated by [methyl-
3H] thymidine incorporation as described in
MATERIALS AND METHODS. Data represents means ± SE (as %
of nonstimulated control) from three to ﬁve independent experiments,
conducted on at least four distinct VVEC populations and at least two
AOEC and MPAEC populations; *P\0.05, **P\0.01 vs. nonsti-
mulated control
Fig. 2 Effects of VEGF, bFGF with and without ATP on DNA
synthesis in VVEC, AOEC, and MPAEC. Growth-arrested (72 h,
serum-free DMEM) vasa vasorum endothelial cells (VVEC), aorta
endothelial cells (AOEC), and main pulmonary artery endothelial
cells (MPA), were stimulated with VEGF (10 ng/ml), bFGF (10 ng/
ml) with or without ATP (100 lM) in the presence of 0.125 lCi [
3H]-
thymidine for 24 h. Incorporated radioactivity was determined in total
cell lysates as described in MATERIALS AND METHODS. The
results are expressed as means ± SE; *P\0.05 vs. nonstimulated
control. Data represent means ± SE (as % of nonstimulated control)
from three to eight independent experiments, conducted on at least
three distinct VVEC and two distinct AOEC and MPAEC popula-
tions; *P\0.05, **P\0.01 vs. nonstimulated control
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123different endothelial cell types (Fig. 5). We found that ATP
induced a greater stimulation of all examined signaling
pathways in VVEC than in AOEC or MPAEC (Fig. 5). In
particular, ATP exerted greater (maximum 10.8 fold
increase) and more prolonged increase in phosphorylation
of ERK1/2 in VVEC than in AOEC (maximum 4.2-fold)
and in MPAEC (maximum 5.0-fold). ATP-induced phos-
phorylation of ERK1/2 was consistently observed in VVEC
at 120 min and was not observed at this time point in
AOEC or MPAEC. ATP-induced phosphorylation of Akt
occurred earlier and was greater in VVEC than in AOEC
and MPAEC (maximal fold increase 5.3, 3.2, and 2.4,
respectively). ATP-induced phosphorylation of mTOR was
greater in VVEC than in AOEC and MPAEC (maximal
fold increase 4.8, 1.8, and 2.2, respectively). Maximal
phosphorylation of p70S6K was also greater and more
prolonged in VVEC than in AOEC and MPAEC (maximal
fold increase 8.9, 2.0, and 2.4, respectively) Thus, in ag-
greement with the robust effect of extracellular ATP on
DNA synthesis, these data support the idea that in adven-
titial VVEC, ERK1/2, PI3K/Akt, and mTOR/p70S6K
pathways contribute to the ATP-dependent pro-angiogenic
phenotype.
Because of the dramatic differences in the activation of
Akt and mTOR/p70S6K pathways observed in VVEC in
response to ATP, we sought to further characterize speciﬁc
upstream events associated with ATP-induced mitogenesis.
It is known that isoforms of class I PI3K containing p110b
catalytic subunit and class II PI3K containing p101c adaptor
protein could be activated in a G-protein-dependent manner
[43, 44]. To demonstrate that activation of PI3K is an
important early signaling event in ATP-mediated VVEC
activation, we measured PI3K activity in an in vitro kinase
assay. In these studies, quiescent cells were stimulated with
ATP (100 lM) for 30 min, and total cell lysates were used
for immunoprecipitation with anti-p85 regulatory subunit,
p110a, anti-p110b, anti-p110d catalytic subunit, or anti-
p101c adaptor protein-speciﬁc antibodies. We found that
PI3K activity was associated with p85, p110b, p101c, and
p110d immunoprecipitates (Fig. 6). Inducing accumulation
of phosphatidylinositol-3-phosphate (PtdIns-3(P)), the
product of lipid kinase activity was observed in p85 and
p110b immunoprecipitates, thus indicating class I PI3Kb in
mediation of the effects of extracellular ATP in VVEC. The
increase of PI3K activity associated with p85 regulatory
subunit in response to ATP was comparable in magnitude to
Fig. 3 Extracellular ATP
induces migration of VVEC but
not AOEC and MPAEC. Panels
a and b: Growth-arrested VVEC
were plated (100,000 cells/well)
in permeable inserts (Falcon
TM,
8.0 lM pore size) in serum-free
DMEM. The lower transwell
compartment contained DMEM
(a), DMEM and 100 lM ATP
(b), DMEM and 2% FBS (c), or
DMEM with 2% FBS and
100 lM ATP (d). After 24 h,
cells remaining on the top of
ﬁlter were wiped off, and cells
on the bottom were ﬁxed with
methanol, stained with 2%
crystal violet, and examined on
a phase contrast microscope at
109 magniﬁcation.
Representative images show
cells that migrated to the lower
side of the ﬁlter. Panel c:
Growth-arrested VVEC, AOEC,
or MPAEC (100,000 cells/well)
were submitted to the migration
assay for 24 h as described
above. Quantitative data on
Panels b and c are means ± SE
from four distinct VVEC
populations and two distinct
AOEC and MPAEC
populations; *P\0.05 vs.
nonstimulated control
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123theeffectof10%fetalbovineserum,usedinourexperiments
as a positive control to evaluate the maximal stimulatory
effect.Nodetectableactivityhasbeenassociatedwithp110a
immunoprecipitates. This is consistent with the role of
PI3Ka isoform in mediating the signaling from receptor
tyrosine kinases, but not G protein-coupled receptors. Sig-
niﬁcant accumulation of PtdIns-3(P) was detected in p110d
andp101cimmunoprecipitatesobtainedfromthecontroland
ATP-stimulated cells, indicating that these isoforms are also
expressedinVVECandmightplayadistinctfunctionalrole.
PI3K/Akt, mTOR/p70S6K, and ERK1/2 pathways play
a critical role in extracellular ATP-induced DNA
synthesis and migration in VVEC
We next determined whether activation of PI3K/Akt,
mTOR/p70S6K, and ERK1/2 pathway is necessary for
ATP-induced DNA synthesis in VVEC. As shown in
Fig. 7, pre-treatment of quiescent endothelial cells with
the PI3K inhibitor LY294002 (20 lM) and the MEK1/2
inhibitor U0126 (10 lM) completely abolished ATP-
Fig. 4 Extracellular ATP
induces VVEC but not AOEC
and MPAEC rearrangements
into tube-like networks on
Matrigel. Panel a: Growth-
arrested VVEC (125,000 cells/
well in 24-well plate), AOEC,
or MPAEC (250,000 cells/well
in 24-well plate), were plated on
growth factor reduced Matrigel
in serum-free DMEM either
with or without ATP (100 lM).
Cells were incubated for 8–
10 h, and photographs were
taken in three ﬁelds with a phase
contrast microscope at 109
magniﬁcation. Representative
images are shown for each cell
type. Panels b–e: Images were
analyzed using AxioVision as
described in Section ‘‘Materials
and methods’’. Quantitative data
represent the means ± SE from
at least three experiments on
two distinct cell populations;
*P\0.05 vs. nonstimulated
control
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123induced increase in [
3H-methyl]-thymidine incorporation.
Pre-treatment with PI3K inhibitor wortmannin (100 nM)
and the inhibitor of mTOR pathway rapamycin (10 nM),
partially, but signiﬁcantly attenuated the response. These
data conﬁrm that PI3K/mTOR and ERK1/2 pathways are
functionally involved in ATP-induced mitogenic signaling
events in VVEC.
Similarly, pre-incubation of VVEC with LY294002,
wortmannin, and U0126 signiﬁcantly diminished ATP-
induced migration. Rapamycin had a partial, but signiﬁcant
inhibitory effect on VVEC migration (Fig. 8). Consistent
with the role of PI3K/mTOR and ERK1/2 in VVEC
proliferation, these data demonstrate that activation of
these pathways is also critically important to extracellular
ATP-induced VVEC migration.
ERK1/2 pathway, but not PI3K/mTOR pathways play
a critical role in extracellular ATP-induced formation
of the tube-like networks in VVEC
Because cell rearrangement in the tube-like networks
requires a proper cell migration, we sought to determine if
PI3K/mTOR and ERK1/2 pathways, are important to this
response. We found that pre-incubation of VVEC with
PI3K and mTOR pathway-speciﬁc inhibitors (LY294002,
wortmannin, rapamycin) had only minor effects in ATP-
Fig. 5 Extracellular ATP robustly activates ERK1/2, PI3K/Akt, and
mTO/p70S6K signaling pathways in VVEC but only modestly in
AOEC and MPAEC. Growth- arrested cells were stimulated with
ATP (100 lM) for the indicated times. Equivalent amounts of total
cell protein (25–40 lg) were subjected to Western blot analysis with
antibodies against phospho-ERK1/2 (Thr202/Tyr204), phospho-Akt
(Ser 473), phospho-mTOR (Thr 2448), and phospho-p70S6K
(Thr421/Ser424). Data shown on each panel illustrate representative
experiments for each cell type. Similar results were reproduced in at
least three independent experiments. The maximal phosphorylation
responses observed within the indicated time frame, are discussed in
the text
Fig. 6 Extracellular ATP increases PI3K activity in VVEC. Growth-
arrested cells DMEM were stimulated with ATP (100 lM) for
30 min. Equivalent amount of total cell protein (500–750 lg) was
immunoprecipitated with rabbit polyclonal antibodies against the
p85a regulatory subunit of PI3K, p110a, p110b, and p110d catalytic
subunits, or against the p101c adaptor protein. PI3K activity was
measured in in vitro kinase assay with a L-a-phosphatidylinositol
(PtdIns) as a substrate. Arrow indicates the accumulation of a product
of PI3K activity, PtdIns(3)P
Fig. 7 PI3K/Akt, mTOR/p70S6K, and ERK1/2 pathways play a
critical role in extracellular ATP-induced DNA synthesis in VVEC.
Growth-arrested VVEC were preincubated with either LY294002
(20 lM, 60 min), wortmannin (100 nM, 120 min), rapamycin
(10 nM, 60 min), U0126 (10 lM, 60 min), or vechicle followed by
stimulation with ATP (100 lM) in the presence of 0.125 lCi [
3H]-
thymidine for 24 h. Incorporated radioactivity was determined in total
cell lysates as described in Materials and Methods. Results are
expressed as percentage of basal thymidine incorporation in control
cells. Data represent the means ± SE from three to ﬁve independent
experiments conducted on three distinct cell populations; *P\0.05
vs. nonstimulated control
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123stimulated cells. (Fig. 9). Calculation of the areas occupied
by the tube-like structures (total tube length and total cell
aggregate diameter) indicated that there were no statisti-
cally signiﬁcant contributions of PI3K and mTOR/p70S6K
pathways to ATP-induced formation of VVEC networks.
(Fig 9b–e). A small, but statistically signiﬁcant effect on
the total and average tube length was observed in U0126-
treated cell pointing out a role for ERK1/2 in this response
(Fig 9a, b). These ﬁndings suggest that extracellular
ATP-induced VVEC rearrangements in the tube-like net-
works requires additional, as yet unidentiﬁed intracellular
signaling pathways.
Discussion
Pathologic angiogenesis plays a pivotal role in the pro-
gression of a variety of diseases. Our previous work has
demonstrated that neonatal hypoxic pulmonary arterial
hypertension is a condition involving pulmonary artery
adventitial thickening, accumulation of inﬂammatory blood
cells, and neovascularization of the adventitial vasa vaso-
rum [3, 4]. Although many factors with angiogenic
potential have been described, factors speciﬁcally involved
in hypoxia-induced expansion of the vasa vasorum neo-
vascularization in the PA have not been delineated. The
ﬁndings of the present study provide strong support for the
idea that extracellular ATP, potentially released from a
variety of cells in the adventitia, including the vasa
vasorum endothelial cells themselves, may be involved in
this process. Our ﬁndings consistently showed that extra-
cellular ATP robustly stimulated angiogenic responses, i.e.,
proliferation, migration, and network formation in Matrigel
in VVEC derived from at least six different chronically
hypoxic animals with pulmonary hypertension, adventitial
remodeling, and vasa vasorum expansion. Interestingly,
ATP had little angiogenic effects on main pulmonary artery
endothelial cells or aortic endothelial cells isolated from
the same animals. Importantly in VVEC, extracellular ATP
potentiates the effect of VEGF and bFGF, other angiogenic
factors known to be produced in hypoxic microenviron-
ment. We found that ATP activated ERK1/2, PI3K/Akt,
and mTOR/p70S6K to a greater degree in VVEC than in
AOEC and MPAEC, and that these signaling pathways
are critical in ATP-induced proliferative and migratory
responses in VVEC. Collectively, our data support the idea
that extracellular ATP participates in the expansion of the
vasa vasorum that is observed in the pulmonary artery
adventitia of chronically hypoxic neonatal calves.
Although extracellular nucleotide-mediated signaling
has been implicated in various physiological and patho-
logic conditions, there is limited information regarding the
role of extracellular nucleotides in modulating endothelial
cell proliferation. We found that extracellular ATP stimu-
lates dramatic increases in DNA synthesis in VVEC, but
has very little effect on AOEC and MPAEC isolated from
the same animals. The exceptional sensitivity of micro-
vascular endothelial cells to stimulation with ATP is
supported by other studies showing a mitogenic effect of
extracellular ATP, UTP, and 2MeSATP on brain capillary
and corneal endothelial cells [45, 46]. The exaggerated
responses to extracellular ATP suggest that VVEC may be
abundantly equipped with multiple purinergic receptors.
However, unexpectedly neither UTP nor UDP stimulated
DNA synthesis in VVEC, though a previous report dem-
onstrated both these pyrimidines stimulate guinea pig
cardiac endothelial cell proliferation [23]. Analysis of
nucleotide efﬁcacy revealed that the P2Y1 family of puri-
nergic receptors, P2Y1, P2Y11, P2Y12, and P2Y13 and
perhaps, P1 adenosine receptors, but not pyrimidine P2Y4
and P2Y6 receptors, play a predominant role in VVEC
mitogenesis. Thus, VVEC appears to display a distinct
phenotype characterized by the expression of a speciﬁc
subset of purinergic receptors. Interestingly, expression of
the subsets of P2Y1-like purinergic receptors has been
reported for several types of immune and circulating blood
cells [24]. When considered in the context of our previous
ﬁndings demonstrating the presence of c-kit + cells in the
newly expanding vasa vasorum [3], these data support the
idea that vasa vasorum neovascularization might involve
both angiogenesis and vasculogenic processes and that
extracellular ATP could be involved in both.
Fig. 8 PI3K/Akt, ERK1/2, and mTOR/p70S6K pathways play a
critical role in extracellular ATP-induced VVEC migration. Growth
arrested VVEC (100,000 cells/well) were plated on top of inserts in
serum free DMEM. Cells were preincubated with LY294002 (20 lM,
60 min) rapamycin (10 nM, 60 min), wortmannin (100 nM,
120 min), U0126 (10 lM, 60 min), or vechicle for 60 min. Cell
migration was stimulated by adding ATP (100 lM) in the lower
transwell compartment. At the end of incubation, cells on the bottom
of ﬁlter were ﬁxed and counted in three ﬁelds at 10X magniﬁcation.
Quantitative data for each experimental condition represent the
means ± SE Similar results were reproduced in at least three
experiments on four distinct cell populations; *P\0.05 vs. nonsti-
mulated control;
#P\0.05 vs. ATP-stimulated cells
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cells derived from large vessels express several types of
purinergic receptors. Expression of P2Y1 and P2Y2
receptors has been shown in bovine aortic endothelial cells
and expression of P2Y1, P2Y2, P2Y6, P2X4, and P2X5
receptors documented in human umbilical vein endothelial
cells [47, 48]. Activation of P2 receptors in these cells
mediates the release of nitric oxide, endothelium-depen-
dent hyperpolarizing factor (EDHF), prostacyclin, and t-PA
[47]. Similar to our observations in AOEC and MPAEC,
Daele et al. have found that ATP and synthetic P2Y
receptor agonists exerted only weak increases in DNA
synthesis in bovine aortic endothelial cells [49]. In addition
to adenine nucleotides, pyrimidine nucleotides, UTP and
UDP have been shown to exert mitogenic and chemotactic
effects on human umbilical vein and guinee pig cardiac
endothelial cells [20, 23]. However, in our studies we did
not observe any stimulatory effect of UTP and UDP, on
DNA synthesis in any of the examined endothelial cell
types. Thus our data, when combined with that from other
reports, suggest that there must be tremendous heteroge-
neity in endothelial phenotypes, with regard to
extracellular nucleotide-induced functional responses and
the signaling pathways through which these effects are
mediated.
To further investigate the possibility that differences in
post-receptor signaling events in VVEC, AOEC and
MPAEC might be involved in conferring distinct prolifer-
ative and migratory phenotypes, we evaluated the
activation of intracellular kinases downstream of P2Y
receptors. We found signiﬁcant differences in the magni-
tude and duration of activation of ERK1/2, Akt, mTOR,
and p70S6K between VVEC and AOEC and MPAEC.
Greater and more prolonged activation of EKR1/2 and
p70S6K in VVEC could contribute to proliferative and
migratory advantages. In fact, we demonstrated that
Fig. 9 Extracellular ATP induces VVEC network formation through
activation of ERK1/2, and not of PI3K/mTOR pathways. Panels a–d:
Growth-arrested VVEC (125,000 cells/well) were plated on growth-
factor-reduced Matrigel in serum free DMEM. Cells were
preincubated with LY294002 (20 lM, 60 min) rapamycin (10 nM,
60 min), wortmannin (100 nM, 120 min), U0126 (10 lM, 60 min),
or vechicle for 60 min. Formation of tube-like networks was
stimulated by the addition ATP (100 lM). At the end of incubation,
images were captured in three ﬁelds using AxioVision program.
Quantitative data for total and average tube (cord) lengths and area of
cell aggregates represent the means ± SE. Similar results were
reproduced in at least three experiments on three distinct cell
populations; *P\0.05 vs. nonstimulated control;
#P\0.05 vs. ATP
stimulated-cells
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123blockade of these pathways inhibited proliferation and
migration. Interestingly, we also observed that ATP in
combination with VEGF or bFGF resulted in more dra-
matic induction of DNA synthesis in VVEC than in other
endothelial cell types. This observation suggests that under
conditions of chronic hypoxia, the simultaneous release of
mitogenic growth factors and nucleotides from vascular
and circulating blood cells may result in cumulative stim-
ulatory effects on proliferation and migration of speciﬁc
endothelial cells, in our case the VVEC.
Enzymatic reactions contributing to the pathways of
extracellular ATP synthesis and degradation play a critical
role in regulating the concentration of extracellular ATP
and its metabolites near purinergic receptors. Recent
studies have implicated the endothelial cell surface ecto-
F1-F0 ATP synthase in endothelial cell and tumor cell
proliferation [50, 51]. It has been shown that both angio-
statin and monoclonal antibodies directed against the b-
subunit of ecto-F1-F0 ATP synthase-inhibited human
umbilical vein endothelial cell proliferation through inac-
tivation of extracellular ATP synthetic pathway [52].
Intringingly, endothelial progenitor cells were found to be
more sensitive to angiostatin than mature endothelial cells
[53]. Given the observations that ATP seems to exert such
potent effects on VVEC proliferation as well as the pos-
sibility that circulating endothelial precursors might be
incorporated at the sites of neovascularization [3], future
experiments directed at an evaluation of ATP synthesis and
degradation pathways on VVEC surface will be important.
Morphogenetic changes in endothelial cells are critical
for appropriate assembly in newly forming blood vessels. It
is believed that formation of a tube-like intercellular net-
work on basement membrane matrix (Matrigel) reﬂects the
ability of endothelial cells to undergo differentiation. To
date, there have been no studies to demonstrate the effect
of extracellular ATP on endothelial rearrengement into the
tube-like networks. Using in vitro Matrigel assay on
growth factor-reduced matrix, we demonstrated that
extracellular ATP exerted signiﬁcant effects on VVEC
tube-like network formation. Interestingly, under basal
conditions, AOEC and MPAEC rearrange in tube-like
networks with a patterns different than those observed for
VVEC. However, in contrast to VVEC, ATP did not exert
signiﬁcant effects on tube-like formation in these cells. The
reasons for these different responses in Matrigel under both
basal and ATP-stimulated conditions exhibited by the dif-
ferent cell types remain unclear and will require future
investigation. They do, however, reinforce the idea that
endothelial cells isolated from different vascular beds,
maintain distinct functional characteristics even after being
perpetuated in culture. The maintenance of these differ-
ences will allow evaluation of vascular bed-speciﬁc
endothelial phenotypes in vitro [54].
Characterization of the signaling pathways contributing
to angiogenesis is important in developing pharmacologic
strategies for both pro- and anti-angiogenic therapy. It has
been shown that constitutive activation of PI3K/Akt/mTOR
and ERK pathways is observed under various pathological
conditions associated with chronic hypoxia, inﬂammation,
and cancer, suggesting that in the hypoxic adventitial
microenvironment, these pathways could play a permissive
role for vasa vasorum growth [43, 55–57]. It has been
previously reported by others and us that ERK1/2 and PI3K
pathways play a critical role in extracellular ATP-induced
proliferation of smooth muscle and ﬁbroblasts [31, 41, 42,
58]. However, the involvement of PI3K and mTOR path-
ways in nucleotide-mediated angiogenic responses in
endothelial cells has not been fully investigated. The results
of our studies demonstrate that extracellular ATP activates
PI3K/Akt, mTOR/p70S6K, and ERK1/2 pathways in
VVEC and that activation of these pathways contributes to
VVEC mitogenic and migratory responses. Using PI3K
isoform-speciﬁc antibodies and in vitro kinase assay, we
found that ATP-stimulated PI3K activity is selectively
associated with the p85 regulatory subunit and p110b cat-
alytic subunit, indicating that at least class I PI3Kb is
involved in ATP-induced mitogenic signaling events in
VVEC. Our observations also suggest a possibility that
PI3Kd, an isoform expressed predominantly in hemato-
poietic cells, may play a role in mediating the effects of
extracellular ATP and/or another angiogenic factors in
VVEC. Complementary to our ﬁndings on the role of PI3K
pathway in endothelial angiogenic responses, studies on
human umbilical vein endothelial cells (HUVEC) demon-
strated the involvement of PI3K, focal adhesion kinase,
p130
cas, and paxillin in extracellular ATP- and UTP-med-
iated cell migration [20]. In addition, activation of ERK and
PI3K/PDK/PKC pathways in response to P2Y receptor
agonists was demonstrated in HUVEC and in U138-MG
human glyoma cell line, demonstrating the ubiquitous role
of extracellular nucleotides and associated PI3K-dependent
pathways in regulating growth responses. Finally, our data
demonstrate that ERK1/2, but not PI3K and mTOR, con-
tributes to extracellular ATP-induced VVEC rearrangement
into tube-like networks in Matrigel, suggesting that addi-
tional, as yet unidentiﬁed signaling pathways are involved
in endothelial tubulogenesis. Recent observations in aortic
and lung microvascular endothelial cells demonstrate that
PLCc/Ca
2+ and cAMP/ERK1/2 pathways may be consid-
ered for their role in the endothelial tube-like formation [59,
60]. Because ATP-mediated activation of VVEC involves
increases in intracellular Ca
2+ level (unpublished observa-
tion), evaluation of PLC/Ca
2+ pathway will be an important
focus of future studies.
In conclusion, our ﬁndings also demonstrate that extra-
cellular ATP is potent angiogenic factor for VVEC, but not
180 Angiogenesis (2008) 11:169–182
123for endothelial cells derived from large systemic and pul-
monary vessels, such as aorta and main pulmonary artery.
The dramatic effect of extracellular ATP on the activation
of PI3K/Akt/mTOR and ERK1/2 pathways suggests that in
VVEC, expression of the components of these signaling
pathways together with P2Y1 purinergic receptors, con-
tributes to a pro-angiogenic phenotype. Finally, the results
of our studies indicate potential signiﬁcance for anti-
angiogenic therapy, in which a combination of purinergic
receptor antagonists with PI3K/mTOR- and ERK1/2-spe-
ciﬁc inhibitors may be considered for eliminating
neovessel growth under pathological conditions where
elevated levels of extracellular ATP and the other purine
nucleotides can be expected.
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